- Home
- ONB vs AXSM Comparison
ONB vs AXSM Comparison
Compare ONB & AXSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ONB | AXSM |
|---|---|---|
| Founded | 1834 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.2B | 10.4B |
| IPO Year | 2012 | 2015 |
Fundamental Metrics
Financial Performance| Metric | ONB | AXSM |
|---|---|---|
| Price | $25.41 | $210.63 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 17 |
| Target Price | $27.25 | ★ $211.12 |
| AVG Volume (30 Days) | ★ 2.9M | 530.8K |
| Earning Date | 04-22-2026 | 05-04-2026 |
| Dividend Yield | ★ 2.46% | N/A |
| EPS Growth | 6.55 | ★ 38.56 |
| EPS | ★ 0.59 | N/A |
| Revenue | ★ $125,616,000.00 | N/A |
| Revenue This Year | $27.93 | $57.24 |
| Revenue Next Year | $5.10 | $55.88 |
| P/E Ratio | $43.41 | ★ N/A |
| Revenue Growth | ★ 6.07 | N/A |
| 52 Week Low | $19.39 | $112.90 |
| 52 Week High | $27.36 | $260.19 |
Technical Indicators
Market Signals| Indicator | ONB | AXSM |
|---|---|---|
| Relative Strength Index (RSI) | 39.71 | 48.24 |
| Support Level | $25.24 | $206.94 |
| Resistance Level | $25.47 | $222.93 |
| Average True Range (ATR) | 0.42 | 6.20 |
| MACD | -0.05 | 1.28 |
| Stochastic Oscillator | 25.00 | 65.34 |
Price Performance
Historical ComparisonAbout ONB Old National Bancorp
Old National Bancorp is a provider of lending and deposit services. The bank offers comprehensive wealth management, trust, investment advisory, brokerage, and foreign currency services. For businesses, it provides treasury management, merchant, and capital markets services as well as community development lending and equity investment solutions intended to produce jobs and revitalize its communities. It earns interest income on loans as well as fee income from the origination of loans and from providing other services to its clients.
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.